From Business: Founded in 2005, Chanticleer Holdings is an investment company that invests in value-based opportunities that are privately held and publicly traded companies. Its holdings…

From Business: Provid specializes in expert medicinal chemistry services to clients in biotech, pharma, and academia. Our expertise lies in translating biological research into valuable drug…

From Business: The Health Strategies Group is a consulting firm that offers research-based sales and marketing intelligence services for the pharmaceutical and biotech industries. Established…

From Business: Palatin Technologies is a biopharmaceutical research and development company with a focus on developing melanocortin-based therapeutics. Additionally, the company has a…

From Business: PharMed Consultants is the unique combination of experience in clinical Hospital Medicine and Hospital Product Commercialization. These competencies enable PharMed Consultants…

From Business: Hurley Consulting Associates is one of the leading international consulting and contract research companies serving the health sciences industry since 1987. The company…

From Business: Enzon Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and other life-threatening…

From Business: Thomson Reuters is the world s leading source of intelligent information for businesses and professionals. it combines industry expertise with innovative technology to deliver…

From Business: Pharmaceutical Product Development Inc. was founded in 1985 in Maryland. One of the leading global contract research organizations (CRO), it provides drug discovery, and…

From Business: GMP Scientific, Inc. is a global consulting firm organized to provide comprehensive services for FDA-regulated companies. We provide cost effective and customized solutions to…

"Don't hire this firm! We hired them for a project and it was sub par. Low prices equals low quality. The "CEO" had no idea how to do a proper market assessment. We had to to…"